PORT WASHINGTON, N.Y. – October 6, 2016 – Pall Life Sciences, a division of global filtration, separation and purification leader Pall Corporation, is pleased to announce that the Cadence Acoustic Separator has won the BioProcess International (BPI) Award for best downstream processing application. Celebrated bi-annually since 2012, the BPI Awards are hosted during the BioProcess International Conference in Boston, MA. The awards exist to celebrate outstanding individual and team achievements that allow the industry to deliver better, more effective treatments to a global patient base. Winners were announced at a dinner on October 5th.
Based on acoustic wave separation technology licensed from FloDesign Sonics*, the Cadence Acoustic Separator was launched in early 2016 as a novel single-use solution for the clarification of cell culture bioprocess fluids. The Cadence Acoustic Separator is a robust platform technology that enables continuous cell separation without centrifugation and dramatically reduced filtration steps for cost-effective preconditioning of the clarified cell culture fluid for downstream processes. The technology is also able to be fully integrated with Pall’s portfolio of continuous downstream bioprocessing technologies.
“We are honored by the recognition of the Cadence Acoustic Separator in 2016, but it is particularly exciting to win this award,” said Michael Egholm, PhD, VP & General Manager of Pall Biopharmaceuticals. “We first introduced the concept of acoustic wave separation for biopharmaceutical applications at last year’s BPI 2015 conference, with the intention of launching in 2016. Thank you to my team, and the team at FloDesign Sonics for partnering with us to develop and launch such a game-changing technology.”
Earlier this year, the Cadence Acoustic Separator technology was awarded second prize for Innovation in an open vote on submitted posters at the Recovery of Biological Products XVII Conference in Bermuda, as well as featured in Pharmaceutical Manufacturing as a 2016 Star Innovation. To learn more about the Cadence Acoustic Separator, and how Pall Life Sciences is continuously improving bioprocesses, please visit: www.pall.com/continuousready
The Cadence Acoustic Separator technology is on display in booth 521 at BPI 2016 this week, among a portfolio of enabling Pall Life Sciences technologies. The displays demonstrate scale up for the clarification application, and a process development approach for perfusion with the AWS technology. Both applications are set to be launched in 2017.
Find the team’s full BPI agenda here: http://www.pall.com/main/biopharmaceuticals/event-details.page?id=20160907061502
* On June 15, 2015, Pall announced the exclusive licensing agreement with FloDesign Sonics (FDS) for acoustic wave separation (AWS) in Bioprocessing
Pall Corporation provides critical fluid management solutions to global life sciences and industrial manufacturing customers. The biopharm division of Pall Life Sciences features an unmatched portfolio of traditional and single-use products with custom service support from R&D to clinical phases to production. Pall is committed to continuously improving bioprocesses to enable users to advance global health with safe, environmentally responsible technologies. Stay up to date with our latest progress at: www.pall.comLinkedInTwitter; and YouTube.

Press Contact
Beth Willers, White Matter Communications


Pall Life Sciences Marketing Contact
 Erin C. Bush, MBA
Senior Manager, Global Product Marketing

More Biotech Press Releases
Read all the latest news and developments from Pall and keep in touch with industry trends and opinion.
April 2020
Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.